Edwards Lifesciences (XSWX:EW) Land And Improvements: CHF0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:EW Edwards Lifesciences Corp XSWX:EW
98 GF Score
Price CHF74.11
GF Value CHF76.30
! 5 Warning Signs
View Full Analysis

What is Edwards Lifesciences Land And Improvements?

Edwards Lifesciences XSWX:EW +3.45% 98 Land And Improvements is CHF0 Mil as of Jun. 2026. GuruFocus rates XSWX:EW with a GF Score™ of 98/100 and a GF Value™ of CHF76.30. The stock has 5 warning signs investors should review.

Edwards Lifesciences's land and improvements for the quarter that ended in Jun. 2026 was CHF0 Mil.

Edwards Lifesciences's quarterly land and improvements declined from Dec. 2025 (CHF121 Mil) to Mar. 2026 (CHF0 Mil) but then stayed the same from Mar. 2026 (CHF0 Mil) to Jun. 2026 (CHF0 Mil).

Edwards Lifesciences's annual land and improvements increased from Dec. 2023 (CHF97 Mil) to Dec. 2024 (CHF110 Mil) and increased from Dec. 2024 (CHF110 Mil) to Dec. 2025 (CHF121 Mil).


Edwards Lifesciences Land And Improvements Historical Data

* Premium members only.

The historical data trend for Edwards Lifesciences's Land And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Edwards Lifesciences Land And Improvements Chart

Edwards Lifesciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Land And Improvements
Get a 7-Day Free Trial Premium Member Only Premium Member Only 107.30 108.35 97.20 110.47 121.45

Edwards Lifesciences Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Land And Improvements Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 121.45 0.00 0.00
XSWX:EW
98GF Score
Edwards Lifesciences Corp XSWX:EW
Land And Improvements is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Edwards Lifesciences Land And Improvements Calculation

Land is the surface or crust of the earth, which can be used to support structures, and may be used to grow crops, grass, shrubs, and trees. Land is characterized as having an unlimited life (indefinite). Land improvement is a long-term asset which indicates the cost of the constructed improvements to land, such as driveways, walkways, lighting, and parking lots.

Frequently Asked Questions Learn more about Land And Improvements →
What does a Land And Improvements of CHF0 Mil mean?
Edwards Lifesciences (XSWX:EW) has a Land And Improvements of CHF0 Mil as of Jun. 2026. Land and improvements records the total value of a company's land and improvements to it. View historical data on Edwards Lifesciences and its competitors.
Is Edwards Lifesciences' Land And Improvements too high?
Edwards Lifesciences' current Land And Improvements is CHF0 Mil. Overall, Edwards Lifesciences has a GF Score™ of 98/100, reflecting its overall financial health beyond just this single metric.
How does Edwards Lifesciences' Land And Improvements compare to BSX and DXCM?
Edwards Lifesciences' Land And Improvements of CHF0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Land And Improvements for a Medical Devices & Instruments company?
A good Land And Improvements depends on the Medical Devices & Instruments industry context. However, Land And Improvements should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Land And Improvements mean?
A high Land And Improvements can signal that a stock is expensive relative to its fundamentals. Land and improvements records the total value of a company's land and improvements to it. View historical data on Edwards Lifesciences and its competitors. Edwards Lifesciences's current Land And Improvements is CHF0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Edwards Lifesciences stock overvalued right now?
Edwards Lifesciences (XSWX:EW) has a current Land And Improvements of CHF0 Mil. The stock's GF Value™ is CHF76.30, compared to a current price of CHF74.11 — trading 2.9% below its estimated fair value. The current Land And Improvements is CHF0 Mil. Edwards Lifesciences' overall GF Score™ is 98/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Land And Improvements calculated?
Land And Improvements is calculated from a company's financial statements. For Edwards Lifesciences (XSWX:EW), the current Land And Improvements is CHF0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Edwards Lifesciences (XSWX:EW) Overvalued in 2026?

Based on GuruFocus' analysis, Edwards Lifesciences stock appears to be undervalued. The current stock price of CHF74.11 is trading 2.9% below its estimated GF Value™ of CHF76.30.

Key valuation signals for XSWX:EW:

  • Land And Improvements: CHF0 Mil
  • GF Value™: CHF76.30 vs. price of CHF74.11 (2.9% below fair value)
  • GF Score™: 98/100 with 5 warning signs

No single metric tells the full story. See the XSWX:EW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Edwards Lifesciences Business Description

Address One Edwards Way, Irvine, CA, USA, 92614
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
98GF Score

Get the complete analysis for XSWX:EW

Land And Improvements is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF74.11
Price
CHF76.30
GF Value